MolNFT v1 · #121993 · protein
Structural analysis of a talin triple domain module, E1794Y, E1797Y, Q1801Y mutant
5IC1 · Talin-1: “Structural analysis of a talin triple domain module, E1794Y, E1797Y, Q1801Y mutant”. X-ray diffraction, 3 pockets (best druggability 0.72). MolNFT v1 #121993 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5IC1
- Type
- protein
- Length
- 464 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Talin-1
- UniProt
- P26039
- Pockets
- 3 · best druggability 0.72
Structure
x-ray diffraction · 1 distinct chain · 81% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Talin-1 | protein | 464 | 81% helix, 0% strand | P26039 |
Ligands and binding sites
- EDO · 1,2-ethanediol · additive · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 703 | 0.72 | 0.79 | 73 | EDO |
| 2 | 73 | 0.40 | 0.79 | 15 | empty |
| 3 | 80 | 0.31 | 0.73 | 18 | empty |
Compared structures
- 5IC1 · Structural analysis of a talin triple domain module, E1794Y, E1797Y, Q1801Y mutant · the same entry in another collection · chain A against A, TM-score 1.00
- P26039 · AlphaFold monomer V2.0 prediction for talin-1 (P26039) · a predicted model of the same protein · chain A against A, TM-score 0.54
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P26039
- Elsewhere: RCSB PDB 5IC1 · PDBe 5IC1 · UniProt P26039
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.